🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is to investigate the safety and efficacy of tumor infiltrating ...
Status
Unknown
Location
Shanghai Tenth People's Hospital
Start Date
2021-01-04
Trial ID
NCT04766320
Treatments Being Tested
This prospective observational study aims to evaluate whether immune profil...
Status
Not Yet Recruiting
Location
SMG-SNU Boramae Medical Center
Start Date
2026-01
Trial ID
NCT07331701
This is a prospective study to investigate the treatment response of Tocili...
Status
Completed
Location
Yunyun Fei
Start Date
2020-07-15
Trial ID
NCT05133895
Treatments Being Tested
To determine the feasibility and safety of administering a regimen of TIL/I...
Status
Terminated
Location
Yale New Haven Hospital
Start Date
2018-02-06
Trial ID
NCT03526185
Treatments Being Tested
This is an open-lable, single-arm, dose escalation and dose extension phase...
Status
Unknown
Location
Cancer Hospital & Institute, Chinese Academy of Medical Sciences
Start Date
2022-09-30
Trial ID
NCT05499715
Treatments Being Tested
This is a phase II clinical study testing a more personalized and lighter c...
Status
Recruiting
Location
Instituto D'Or de Pesquisa e Ensino de Brasília
Start Date
2025-10-31
Trial ID
NCT07074106
Treatments Being Tested
Prospective, single-center, single-arm, open-label,interventional study eva...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2022-10-08
Trial ID
NCT05539768
Treatments Being Tested
This phase II trial studies how well autologous tumor infiltrating lymphocy...
Status
Active Not Recruiting
Location
M D Anderson Cancer Center
Start Date
2018-04-27
Trial ID
NCT03449108
This randomized phase II trial studies how well giving pembrolizumab with s...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2015-08-07
Trial ID
NCT02500576
RATIONALE: Drugs used in chemotherapy such as cyclophosphamide and fludarab...
Status
Completed
Location
Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office
Start Date
2003-06
Trial ID
NCT00062036